Sorrento Therapeutics

3 followers

Sorrento Therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases.

Industries

Employees

51-200

Links


Org chart

Henry Ji
Chairman, President & CEO
Collapse
Wenzhong Guo
Chief Technical Officer, Cell Therapy
Mark R. Brunswick
SVP, Regulatory Affairs
Shawn Sahebi
SVP, Commercial Operations
Hui Xie
Executive Director, Nanoformulations
Hong Zhang
Executive Director
Run Shen
Head Of Process Development And Manufacturing